glp 1 agonisten GLP-1 Agonists: A Comprehensive Overview Mechanism of action of GLP-1
Description
TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial
The most important unknowns (cardiovascular safety, evidence on hard kidney outcomes, head-to-head tirals etc) all report between now and 2028
eClinicalMedicine 69 , 102475 (2024)
Contrasting effects of lixisenatide and liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: A randomized, open-label trial
19 25 hours) [ Table 1 ]
[DOI] [PubMed] [Google Scholar] 646.Kumarathurai P., Anholm C., Fabricius-Bjerre A., Nielsen O.W., Kristiansen O., Madsbad S
